KG
IART icon

Kilter Group’s Integra LifeSciences IART Stock Holding History

Kilter Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04K Sell
58
-140
-71% -$1.96K ﹤0.01% 1269
2026
Q1 		$1.87K Buy
+198
New +$2.17K ﹤0.01% 979

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Kilter Group's IART Position: Q2 2026 in Review

Kilter Group reduced its Integra LifeSciences (IART) stake by 71% in Q2 2026, selling an estimated $1.96K and leaving 58 shares worth $1.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1269.

Kilter Group first reported a position in IART in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.87K in Q1 2026. 212 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Kilter Group held 58 shares of Integra LifeSciences worth $1.04K as of Q2 2026.
  • Kilter Group sold 140 Integra LifeSciences shares in Q2 2026, an estimated $1.96K.
  • Integra LifeSciences made up ﹤0.01% of Kilter Group's portfolio in Q2 2026, its #1269 holding.
  • Kilter Group first reported a position in Integra LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • Kilter Group's Integra LifeSciences position peaked at $1.87K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.